BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26524625)

  • 1. Novel chiral-diazepines function as specific, selective receptor agonists with variable coupling and species variability in human, mouse and rat BRS-3 receptor cells.
    Ramos-Álvarez I; Nakamura T; Mantey SA; Moreno P; Nuche-Berenguer B; Jensen RT
    Peptides; 2016 Jan; 75():8-17. PubMed ID: 26524625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel chiral diazepines as bombesin receptor subtype-3 (BRS-3) agonists with low brain penetration.
    Matsufuji T; Shimada K; Kobayashi S; Kawamura A; Fujimoto T; Arita T; Hara T; Konishi M; Abe-Ohya R; Izumi M; Sogawa Y; Nagai Y; Yoshida K; Takahashi H
    Bioorg Med Chem Lett; 2014 Feb; 24(3):750-5. PubMed ID: 24412111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
    Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
    Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
    Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM; Nitecki DE; Biancalana S; Feldman RI
    Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
    Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
    Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
    J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology and pharmacology of bombesin receptor subtype-3.
    Majumdar ID; Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):3-7. PubMed ID: 22157398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.
    Uehara H; González N; Sancho V; Mantey SA; Nuche-Berenguer B; Pradhan T; Coy DH; Jensen RT
    Peptides; 2011 Aug; 32(8):1685-99. PubMed ID: 21729729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
    Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of bombesin receptor subtype-specific ligands: effect of N-methyl scanning, truncation, substitution, and evaluation of putative reported selective ligands.
    Mantey SA; Gonzalez N; Schumann M; Pradhan TK; Shen L; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2006 Nov; 319(2):980-9. PubMed ID: 16943256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel chiral diazepine derivatives as bombesin receptor subtype-3 (BRS-3) agonists incorporating an antedrug approach.
    Matsufuji T; Shimada K; Kobayashi S; Ichikawa M; Kawamura A; Fujimoto T; Arita T; Hara T; Konishi M; Abe-Ohya R; Izumi M; Sogawa Y; Nagai Y; Yoshida K; Abe Y; Kimura T; Takahashi H
    Bioorg Med Chem; 2015 Jan; 23(1):89-104. PubMed ID: 25497965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
    Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
    Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
    Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
    Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.
    Moreno P; Mantey SA; Lee SH; Ramos-Álvarez I; Moody TW; Jensen RT
    Peptides; 2018 Mar; 101():213-226. PubMed ID: 29410320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Characterization of a Novel, High-Affinity, Specific, Radiolabeled Ligand for BRS-3 Receptors.
    Ramos-Alvarez I; Lee L; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 2019 Jun; 369(3):454-465. PubMed ID: 30971479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective human bombesin receptor subtype-3 peptide agonist mediates CREB phosphorylation and transactivation.
    Qin X; Qu X; Coy D; Weber HC
    J Mol Neurosci; 2012 Jan; 46(1):88-99. PubMed ID: 22127929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.
    Moody TW; Mantey SA; Moreno P; Nakamura T; Lacivita E; Leopoldo M; Jensen RT
    Peptides; 2015 Feb; 64():55-61. PubMed ID: 25554218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.